Sunday, 09 August 2026

'Magic Mushrooms' Could be New Solution to Quitting Smoking

BT Lifestyle Desk
Disclosure : 02 May 2026, 01:32 PM
Johns Hopkins study, 52% of participants using psilocybin therapy remained abstinent from smoking after six months.
Johns Hopkins study, 52% of participants using psilocybin therapy remained abstinent from smoking after six months.

New research suggests that psychedelic drugs could help smokers overcome nicotine addiction by fundamentally shifting their worldview and life priorities.

Nicotine is notoriously difficult to quit, often compared to the addictive grip of cocaine or heroin. While 70% of smokers express a desire to stop, fewer than 10% succeed annually. However, a groundbreaking study from Johns Hopkins University indicates that psilocybin the active compound in "magic mushrooms" could offer a powerful alternative to traditional methods.

The Power of Perspective

According to Matthew Johnson, a professor at Johns Hopkins, the effectiveness of psychedelics may be philosophical. Participants in a 2026 study reported a sudden shift in values, feeling that smoking no longer served their life goals. "The magnitude of the experience overshadowed the psychological challenge of quitting," Johnson noted.

In a trial involving 82 participants, those who received a high dose of psilocybin combined with talk therapy were significantly more successful than those using nicotine patches. Six months later, 52% of the psilocybin group remained smoke-free, compared to just 25% of the patch group.

How It Works: Reopening the Brain

Scientists believe the drug creates "behavioral plasticity." Neuroscientists at UC Berkeley suggest psychedelics may reopen "critical periods" in the brain windows of heightened learning usually seen in childhood. When combined with cognitive behavioral therapy, this allows the brain to "reprogram" itself and break long-standing habits.

A Cautious Path Forward

Despite the excitement, experts urge caution. Psychedelics remain illegal in most countries, and research is tightly controlled. Critics point out that current studies are small and lacked diversity. To address this, the U.S. National Institutes of Health (NIH) recently awarded a $4 million grant the first in 50 years for psychedelic therapy to conduct a larger, multi-site trial.

While addiction remains a complex issue, researchers believe integrating psychedelics with therapy and healthy habits like mindfulness could provide a creative solution to the world's leading preventable cause of death.

  • Latest

  • Popular

Donald Trump Hates Taylor Swift; White House Removed Songs From Campaign

1

11-Party Alliance Names Col (Retd) Oli Ahmed as Presidential Candidate

2

Students Block Dhaka-Mymensingh Highway Demanding Footbridge After Classmate's Death

3

US Envoy Visits Bhimruli Floating Market in Jhalokati

4

Three Killed Three Injured in Bogura Highway Collision

5

Jagannath University Admission Tests to Begin January 1

6

PM Tarique Rahman Inspects Matarbari Projects and Flood Recovery Efforts

7

BNP Collects Two Nomination Papers for Presidential Election

8

Whitney Houston's No. 1 Hits Album "WH1TNEY" Marks Her Birthday

9

Microplastics found in smokers’ blood, possible heart disease link

10

FIFA Defends President Infantino Amid UEFA Exit Payment Allegations

11

Weight-Loss Drugs Also Cutting Alcohol Cravings

12

Master Plan Announced to Protect St. Martin’s Island

13

Four Dead in a Helicopter Crashes in Brazil's Rio de Janeiro

14

PM Gifts CNG Auto-Rickshaw to Bullet-Injured July Uprising Student

15

Lionel Messi's Father Jorge Messi Dies at 68 After Long Illness

16

Objective Journalism Vital for Society: NU Vice-Chancellor

17

Coast Guard Seizes 30kg Marijuana in Bhola Arrests One

18

Tarique Rahman Visits Cox’s Bazar Chattogram to Inspect Projects and Lead Flood Relief

19

HSC Exams End Nationwide, Results Expected in November

20